Khiron Life Sciences Corp.: Invitation to the Benzinga Virtual Cannabis Capital Conference

Khiron Life Sciences Corp. (TSXV: KHRN) will be presenting at the Benzinga Cannabis Capital Conference taking place on February 25-26, 2021. We invite our shareholder and all interested parties to join us for a full day of networking, dealmaking and discovery. Sign up to get a free spectator pass for the event: https:events.benzinga.comccc-free-registration.

About Benzinga Cannabis Capital Conference

Benzinga's virtual Cannabis Capital Conference is guaranteed to offer participants all the benefits of an immersive and robust in-person conference from any remote location. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space. Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe.

For more information and/or to register for the conference please visit: https://events.benzinga.com/ccc-free-registration.

We look forward to seeing you there.

For further information:

Khiron Life Sciences Corp.
Paola Ricardo
(647) 556-5750
investors@khiron.ca
https://investors.khiron.ca/corporate-information

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Khiron Life Sciences

Khiron Life Sciences

Overview

As a vertically integrated cannabis leader with global growth, Khiron Life Sciences Corp. (TSXV:KHRN,OTCQB:KHRNF,FWB:A2JMZC) targets a market of 620 million people in Latin America. Khiron has operations in Colombia, Uruguay, Chile and a presence in Peru and Mexico.

Khiron has cultivation capabilities in multiple jurisdictions and is engaged in the production, distribution, marketing and export of THC and CBD cannabis. Khiron is leading scientific research, clinical trials and education programs, owns and operates a network of medical clinics that treat 100,000 patients annually, and holds endorsements from the foremost medical associations in the region.

Keep reading...Show less

Discover the evolution of cannabis as Khiron Life Sciences brings its unique medicinal cannabis products to the Latin American, US and global markets.

Latest Press Releases

Related News

×